ANDA 214997, held by Regcon Holdings. Iloprost.
As of Nov 14, 2026, ANDA 214997 (Iloprost), held by Regcon Holdings, was first approved by FDA on Jul 10, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 10, 2026 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
